Latest It Distribution News

SportsHero Limited has inked a pivotal two-year distribution agreement with PLDT Inc in the Philippines, raised $1.65 million through a private placement, and broadened its mobile gaming footprint across Southeast Asia with new content partnerships.

Codeifai Limited reports a 10% revenue increase in Q3 2025 and completes due diligence on the QuantumAI Secure platform acquisition, signaling a strategic pivot into quantum-resilient fintech solutions.

Osteopore Limited reported a 7% year-on-year revenue increase in Q3 CY25, secured Swiss market approval for its implants, and saw a threefold sales surge through its Zimmer Biomet partnership.

Novatti Group has achieved positive operating cashflow and EBITDA for the September quarter, driven by strategic revenue reforms and new commercial contracts with major clients.

Livium Ltd has completed its strategic pivot to focus on recycling clean energy waste, reporting solid Q1 FY26 results and securing a significant capital raise to fuel expansion into battery, solar panel, and rare-earth element recycling.

BCAL Diagnostics has secured key partnerships and a $10 million convertible note facility to expand its cancer detection tests across Australia and New Zealand, marking steady commercial progress in Q3 2025.

Strickland Metals delivers robust drilling results at its Serbian Rogozna Project, revealing new high-grade copper-gold zones and expanding gold mineralisation footprints, while completing the sale of its Yandal Project to Gateway Mining.

TPG Telecom is set to return approximately $3 billion to shareholders through a capital reduction and special dividend, pending a final tax ruling from the Australian Taxation Office.

Hydralyte USA reported a 6% year-on-year sales increase in Q3 FY25 alongside a significant 42% reduction in operating cash burn, driven by a streamlined US-focused model and new product launches in brain and gut health.

Holista Colltech reported improved cash flow management and robust growth in its dietary supplements division for 3QFY25, while navigating ongoing legal challenges with ProImmune.

Aumake Limited reported a near-breakeven quarter with strong cash receipts and launched a new health product brand while securing a strategic partnership to expand Australian agricultural exports to China.

Control Bionics reports a strong start to FY26 with nearly 10% revenue growth, expanded US reimbursement coverage, and advancing commercialization of its NeuroNode and NeuroStrip technologies.